Together, human blood and mouse brain samples with a SOD1 mutation in the same position seem to converge on the same molecular dysfunction (i.e., impaired ATF3 signaling) within the context of ALS. This evidence concerns the gene ATF3 and amyotrophic lateral sclerosis.